Company / Cash per Share
Corbus Pharmaceuticals Holdings, Inc. Cash per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.08
FY2022
5-year range
$0.25 / $4.08
FY2018-FY2022
Trend
+1512.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +1512% YoY in FY2022, a notable deviation from the 7-year average annual change of +267%.
Based on SEC 10-K filings.
4.08 in FY2022 with a 5-year CAGR of +19.6%.
Improved from $1.32 to $4.08 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +94.5%
- 5-Year CAGR
- +19.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, cash per share increased 1512.0% year-over-year.
- Lowest cash per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $4.08 | +1512.0% |
| FY2021 | $0.25 | -80.9% |
| FY2020 | $1.32 | +138.2% |
| FY2019 | $0.55 | -26.1% |
| FY2018 | $0.75 | -54.9% |
| FY2017 | $1.66 | +317.1% |
| FY2016 | $0.40 | +65.1% |
| FY2015 | $0.24 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026